Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,164
Follow-up Visit of High Risk Infants
for
Infant, Newborn, Infant, Low Birth Weight,
Location: Cincinnati OH, Indianapolis IN, Cleveland OH,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 1 - 2
Code: NCT00009633
Recruiting
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
for
Acute Pancreatitis
Location: Cincinnati OH, Charlotte NC, Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT04195347
Phase1, Phase2, Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
for
Allogeneic Hematopoietic Cell Transplantation
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0+
Code: NCT05501756
Phase2, Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Cincinnati OH, Ann Arbor MI, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase2, Phase3, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Cincinnati OH, Akron OH, Detroit MI, Oak Lawn IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,